07:00:14 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



News for C:CRDL from 2023-04-26 to 2024-04-25 - 23 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-04-17 13:49C:CRDLCardiol Therapeutics Inc2.415Warrants ExpireCardiol Therapeutics warrants to expire May 13
2024-04-02 09:26C:CRDLCardiol Therapeutics Inc2.58News ReleaseCardiol Therapeutics recaps 2023 operations
2024-04-01 19:04C:CRDLCardiol Therapeutics Inc2.58SEDAR Annual ReportSEDAR Annual Report
2024-04-01 18:57C:CRDLCardiol Therapeutics Inc2.58SEDAR MD & ASEDAR MD & A
2024-04-01 18:45C:CRDLCardiol Therapeutics Inc2.58SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-02-21 11:23C:CRDLCardiol Therapeutics Inc2.25News ReleaseCardiol completes patient enrolment for CardiolRx study
2024-02-15 09:28C:CRDLCardiol Therapeutics Inc1.42News ReleaseCardiol receives orphan drug designation for CardiolRx
2024-01-24 11:08C:CRDLCardiol Therapeutics Inc1.52News ReleaseCardiol regains Nasdaq listing standard compliance
2024-01-09 11:35C:CRDLCardiol Therapeutics Inc1.36News ReleaseCardiol enrolls over 50% of patients in Archer study
2023-12-05 11:11C:CRDLCardiol Therapeutics Inc1.29News ReleaseCardiol adds Mass. General Hospital to CardiolRx study
2023-11-16 09:18C:CRDLCardiol Therapeutics Inc1.14News ReleaseCardiol presents CardiolRx study results at MPD2023
2023-11-14 16:45C:CRDLCardiol Therapeutics Inc1.19SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 16:41C:CRDLCardiol Therapeutics Inc1.19SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-01 10:27C:CRDLCardiol Therapeutics Inc1.17News ReleaseCardiol enrolls over 50% of patients in CardiolRx study
2023-10-20 17:16C:CRDLCardiol Therapeutics Inc0.94News ReleaseCardiol's share price sinks below Nasdaq $1 (U.S.) min.
2023-10-10 10:00C:CRDLCardiol Therapeutics Inc1.18News ReleaseCardiol's CRD-38 study shows cardioprotective effects
2023-09-19 10:39C:CRDLCardiol Therapeutics Inc1.31News ReleaseCardiol expects full enrolment in Archer phase 2 trial
2023-08-10 17:07C:CRDLCardiol Therapeutics Inc1.31SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-08 12:53C:CRDLCardiol Therapeutics Inc1.60News ReleaseCardiol Therapeutics meets Nasdaq minimum bid price
2023-06-29 16:13C:CRDLCardiol Therapeutics Inc1.06News ReleaseCardiol shareholders elect eight directors at AGM
2023-06-27 12:38C:CRDLCardiol Therapeutics Inc1.05News ReleaseCardiol Therapeutics to hold virtual AGM June 28
2023-05-15 16:20C:CRDLCardiol Therapeutics Inc0.74SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-15 16:20C:CRDLCardiol Therapeutics Inc0.74SEDAR MD & ASEDAR MD & A